“Atypical haemolytic uraemic syndrome (aHUS) is one disease where you really don’t want to wait until you see clinical signs until you act. By that stage there’s already end-organ damage and with that comes a whole raft of complexities,” notes Danny Hsu, Consultant Haematologist, Liverpool Hospital. The limbic spoke with Dr Hsu about how the ...
The evolving management of aHUS: what clinicians need to know
21 Nov 2019
Sponsored by Alexion Pharmaceuticals Australasia Pty Ltd